Blue Zone Wealth Advisors LLC Purchases 1,054 Shares of Veeva Systems Inc. (NYSE:VEEV)

Blue Zone Wealth Advisors LLC lifted its position in shares of Veeva Systems Inc. (NYSE:VEEV) by 7.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,694 shares of the technology company’s stock after purchasing an additional 1,054 shares during the period. Blue Zone Wealth Advisors LLC’s holdings in Veeva Systems were worth $3,300,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in VEEV. MassMutual Private Wealth & Trust FSB lifted its position in shares of Veeva Systems by 72.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock valued at $25,000 after purchasing an additional 50 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC bought a new position in shares of Veeva Systems during the third quarter valued at about $26,000. True Wealth Design LLC increased its holdings in Veeva Systems by 3,375.0% during the third quarter. True Wealth Design LLC now owns 139 shares of the technology company’s stock worth $29,000 after buying an additional 135 shares during the last quarter. Avion Wealth increased its holdings in Veeva Systems by 635.0% during the fourth quarter. Avion Wealth now owns 147 shares of the technology company’s stock worth $30,000 after buying an additional 127 shares during the last quarter. Finally, Retirement Wealth Solutions LLC purchased a new stake in Veeva Systems during the fourth quarter worth about $31,000. 88.20% of the stock is owned by institutional investors.

Analyst Ratings Changes

VEEV has been the subject of a number of research analyst reports. Morgan Stanley raised their price objective on shares of Veeva Systems from $183.00 to $195.00 and gave the stock an “underweight” rating in a report on Tuesday, December 17th. Wells Fargo & Company raised their price objective on shares of Veeva Systems from $275.00 to $285.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. StockNews.com downgraded shares of Veeva Systems from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Truist Financial decreased their price objective on shares of Veeva Systems from $261.00 to $210.00 and set a “hold” rating for the company in a report on Monday, January 13th. Finally, Evercore ISI raised their price objective on shares of Veeva Systems from $220.00 to $245.00 and gave the stock an “in-line” rating in a report on Friday, December 6th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and seventeen have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $253.96.

Veeva Systems Price Performance

Shares of Veeva Systems stock opened at $234.09 on Friday. Veeva Systems Inc. has a 1 year low of $170.25 and a 1 year high of $258.93. The firm has a market cap of $38.00 billion, a PE ratio of 57.80, a PEG ratio of 1.97 and a beta of 0.85. The company has a 50 day simple moving average of $224.48 and a two-hundred day simple moving average of $215.96.

Insider Transactions at Veeva Systems

In other news, SVP Jonathan Faddis sold 1,694 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $230.30, for a total value of $390,128.20. Following the completion of the sale, the senior vice president now directly owns 8,061 shares in the company, valued at approximately $1,856,448.30. The trade was a 17.37 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 10.50% of the company’s stock.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.